MedDataX Logo

Effect of a Nutritional Supplement on H&N Cancer Patients

NCT ID: NCT00296452

Last Updated: 2006-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-02-28

Study Completion Date

2006-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine if using a nutritionally enhanced supplement will improve mucositis in head and neck cancer patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

H\&N cancer patients will be randomized to receive either a nutritionally enhanced product or standard treatment. The patients in both groups will receive nutritional counseling weekly by the RD. Anthropometric measures, available lab values, mucositis grade, and quality of life measures will be compared between groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Head and Neck Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

cancer nutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

behavior

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Head and neck cancer 1st.2nd wk Rx read \&wrte eng

Exclusion Criteria

* receiving hospice impaired cognition
Minimum Eligible Age

30 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Edward Hines Jr. VA Hospital

FED

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sharon Foley, MS

Role: PRINCIPAL_INVESTIGATOR

Hines VA Hosptial

carol bier-laning, MD

Role: PRINCIPAL_INVESTIGATOR

Hines VA Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Edward Hines, Jr. VA Hospital

Hines, Illinois, United States

Site Status RECRUITING

Hines VA Hospital

Hines, Illinois, United States

Site Status SUSPENDED

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sharon Foley, MS

Role: CONTACT

Phone: 708-202-2343

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sharon Foley, MS

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0033

Identifier Type: -

Identifier Source: org_study_id